-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Axsome Therapeutics, Raises Price Target to $223

Benzinga·01/16/2026 16:40:55
Listen to the news
Piper Sandler analyst David Amsellem maintains Axsome Therapeutics (NASDAQ:AXSM) with a Overweight and raises the price target from $148 to $223.